CGC Publications and Presentations
CGC Publications and Presentations
*Note: To access full length articles, you must be logged into your CGC account.2020
Evidence-Based Review of Genomic Aberrations in B-Lymphoblastic Leukemia/Lymphoma: Report from the Cancer Genomics Consortium Working Group for Lymphoblastic Leukemia
Yassmine Akkari, Helene Bruyere, R. Tanner Hagelstrom, Rashi Kanagal-Shamanna, Jie Liu, Minjie Luo, Fady M. Mikhail, Beth A. Pitel, Gordana Raca, Mary Shago, Lina Shao, Lisa R. Smith, Teresa A. Smolarek, Ashwini Yenamandra, Linda B. Baughn, on behalf of the Cancer Genomics Consortium B-ALL Working Group
Cancer Genet. 2020; 243:52-72.
Pubmed Access Full Article
Current Concepts in Breast Cancer Genomics: An Evidence-Based Review by the CGC Breast Cancer Working Group
Katherine B. Geiersbach, Hui Chen, Rajyasree Emmadi, Gloria T. Haskell, Xinyan Lu, Yajuan J. Liu, Karen Swisshelm, on behalf of the Cancer Genomic Consortium Breast Cancer Working Group
Cancer Genet. 2020 Jun;244:11-20.
Pubmed Access Full Article
Assessing Genome-wide Copy Number Aberrations as Best Practice for Renal Cell Neoplasia: An Evidence-Based Review from the Cancer Genomics Consortium Workgroup
Yajuan J. Liu, Jane Houldsworth, Rajyasree Emmadi, Lisa Dyer, Daynna J. Wolff, on behalf of the Cancer Genomics Consortium Renal Neoplasia Working Group
Cancer Genet. 2020 Jun;244:240-254
Pubmed Access Full Article
Copy Number Assessment in the Genomic Analysis of CNS Neoplasia: An Evidence-Based Review from the Cancer Genomics Consortium (CGC) Working Group on Primary CNS Tumors
Stewart G. Neill, Jennifer Hauenstein, Marilyn M. Li, Yajuan J Liu, Minjie Luo, Debra F. Saxe, Azra H. Ligon, on behalf of the Cancer Genomics Consortium CNS Tumor Working Group
Cancer Genet. 2020 May; 243:19-47.
Pubmed Access Full Article
2019
Technical laboratory standards for interpretation and reporting of acquired copy-number abnormalities and copy-neutral loss of heterozygosity in neoplastic disorders: a joint consensus recommendation from the American College of Medical Genetics and Genomics (ACMG) and the Cancer Genomics Consortium (CGC).
Fady M. Mikhail , Jaclyn A. Biegel, Linda D. Cooley, Adrian M. Dubuc, Betsy Hirsch, Vanessa L. Horner , Scott Newman, Lina Shao, Daynna J. Wolff, Gordana Raca.
Genet Med. 2019 May 21(9):1903-1916.
Pubmed
2018
Assessing Copy Number Aberrations and Copy Neutral Loss of Heterozygosity Across the Genome as Best Practice: An Evidence Based Review of Clinical Utility from the Cancer Genomics Consortium (CGC) Working Group for Myelodysplastic Syndrome, Myelodysplastic/Myeloproliferative and Myeloproliferative Neoplasms
Rashmi Kanagal-Shamanna, Jennelle C.Hodge, Tracy Tucker, Shashi Shetty, Ashwini Yenamandra, Amanda Dixon-McIver, Christine Bryke, Emma Huxley, Patrick A.Lennon, Gordana Raca, Xinjie Xu, Sally Jeffries, Fabiola Quintero-Rivera, Patricia T. Greipp, Marilyn L.Slovak, Anwar Iqbal, Min Fang, on behalf of the Cancer Genomics Consortium MDS/MPN Working Group
Cancer Genet. 2018 Dec; 228-229: 197-217
Pubmed Access Full Article
Assessing copy number abnormalities and copy-neutral loss-of-heterozygosityacross the genome as best practice in diagnostic evaluation of acute myeloidleukemia: An evidence-based review from the cancer genomics consortium (CGC) myeloid neoplasms working group
Xinjie Xu, Christine Bryke, Madina Sukhanova, Emma Huxley, D P Dash, AmandaDixon-Mciver, Min Fang, Patricia Griepp, Jennelle C. Hodge, M. Anwar Iqbal,Sally Jeffries, Rashmi Kanagal Shamanna, Fabiola Quintero-Rivera, Shashi Shetty, Marilyn Slovak, Ashwini Yenamandra, Patrick A. Lennon, and Gordana Raca, on behalf of the Cancer Genomic Consortium Myeloid Neoplasm Working Group
Cancer Genet. 2018 Dec;228-229: 218-235
Pubmed Access Full Article
Assessing Copy Number Aberrations and Copy-neutral Loss-of-Heterozygosity Across the Genome as Best Practice: An Evidence-Based Review from the Cancer Genomics Consortium (CGC) Working Group for Chronic Lymphocytic Leukemia.
Kathy Chun, Gail D. Wenger, Alka Chaubey, D.P. Dash, Rashmi Kanagal-Shamanna, Sibel Kantarci, Ravindra Kolhe, Daniel L. Van Dyke, Lu Wang, and Patricia M. Miron, on behalf of the Cancer Genomic Consortium CLL Working Group
Cancer Genet. 2018 Dec; 228-229:236-250
Pubmed Access Full Article
Assessing Genome-wide Copy Number Aberrations and Copy-Neutral Loss-of-Heterozygosity as Best Practice: An Evidence-Based Review from the Cancer Genomics Consortium Working Group for Plasma Cell Disorders
Trevor J. Pugh , James M. Fink , Xinyan Lu , Susan Mathew, Joyce Murata-Collins, Pascale Willem, Min Fang, on behalf of the Cancer Genomics Consortium Plasma Cell Disorders Working Group
Cancer Genet. 2018 Dec; 228-229:184-196
Pubmed Access Full Article
2015
A multicenter, cross-platform clinical validation study of cancer cytogenomic arrays
Marilyn M. Li, Federico A. Monzon, Jacyln A. Biegel, Vaidehi Jobanputra, Jennifer J. Laffin, Brynn Levy, Annette Leon, Patrician Miron, MIchael R. Rossi, Gokce Toruner, Karla Alvarez, Gregory Doho, Margaret J. Dougherty, Xiaofeng Hu, Shera Kash, Deanna Streck, Iya Znoyko, Jill M. Hagenkord, Daynna J. Wolff.
Cancer Genet. 2015 Nov; 208(11):525-536.
Pubmed Access Full Article
